Notice of Early Expiration of PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)"
Notice Number:
NOT-GM-21-006

Key Dates

Release Date:

December 7, 2020

Related Announcements

PAR-20-039 - Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)

NOT-GM-21-003 - Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence (SuRE)

NOT-GM-21-008 - Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence - First Independent Research Support & Transition (SuRE-First)

NOT-GM-21-009 - Notice of Intent to Publish a Funding Opportunity Announcement for Regional Coordinating Center for the Support for Research Excellence (SuRE) Program

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to alert potential applicants to the early expiration of PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)." This FOA will expire on May 8, 2021.


The FOA has been updated accordingly.

Part 1. Key Dates

The FOA currently reads:

Application Due Date(s)

January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; May 7, 2022 and September 7, 2022

All applications are due, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

July 2020, November 2020, July 2021, November 2021, July 2022, November 2022

Advisory Council Review

October 2020, January 2021, October 2021, January 2022, October 2022, January 2023

Earliest Start Date

January 2021, April 2021, January 2022, April 2022, January 2023, April 2023

Expiration Date

September 8, 2022

The FOA is modified to read:

Application Due Date(s)

January 25, 2020; May 25, 2020; January 25, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

May 7, 2020; September 7, 2020; May 7, 2021

All applications are due, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

July 2020, November 2020, July 2021

Advisory Council Review

October 2020, January 2021, October 2021

Earliest Start Date

January 2021, April 2021, January 2022

Expiration Date

May 8, 2021

All other aspects of this FOA remain unchanged
 

Inquiries

Please direct all inquiries to:

Irina N. Krasnova, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: irina.krasnova@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices